BridgeBio Oncology Therapeutics, Inc.

BBOT · Nasdaq · SIC 2834: Pharmaceutical Preparations
25
SEC Filings

Business Summary

PART I Item 1. Bus iness. Overview BBOT is a clinical-stage biotechnology company with the mission of transforming the lives of patients with cancers driven by RAS and PI3K, the two most frequently mutated oncogenes. Aberrant RAS signaling drives uncontrolled tumor growth in some of the deadliest cancers, including lung, breast, pancreas and colon cancer. This can come from mutations in RAS itself, which underlie approximately 30% of all human cancers, or from RAS-mediated overactivation of PI3K...

Next Earnings

Q2 FY2026 — expected 2026-08-08

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBBOTdiscussed_in_filing Cybersecurity
topic_mentionBBOTdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001193125-26-094112EDGAR111K words
2025-03-112024-12-310001213900-25-022387EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-277834EDGAR78K words
2025-08-012025-06-300001213900-25-070659EDGAR—
2025-05-152025-03-310001213900-25-044424EDGAR—
2024-11-142024-09-300001213900-24-098483EDGAR—
2024-08-142024-06-300001213900-24-068630EDGAR—
2024-05-152024-03-310001213900-24-043582EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001193125-26-126493EDGAR1K words
2026-03-050001193125-26-093997EDGAR—
2026-01-070001193125-26-005425EDGAR—
2025-11-120001193125-25-277601EDGAR—
2025-08-130001213900-25-075190EDGAR—
2025-08-060001213900-25-072312EDGAR—
2025-08-040001213900-25-071392EDGAR—
2025-07-110001213900-25-062955EDGAR—
2025-03-030001213900-25-018997EDGAR—
2025-02-280001213900-25-018334EDGAR—

25 total filings indexed. 7 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001869105
TickerBBOT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 1638f71777e5a893fce7ef9128e0d55d2d9bda1b452aecaab6af830c450adb84
parent: c9e586fc899b07708bf4596e8edd86183087834e034e6c63cf7907556710f869
content hash: 08b78593fcb1350b629b24d40898fc10a05e3c4e5cd58234fcde40048fae88a2
signed: 2026-04-13T04:43:53.269Z
sources: 8 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf